Company Filing History:
Years Active: 1996-2009
Title: The Innovative Contributions of Bertha K. Madras
Introduction
Bertha K. Madras is a prominent inventor based in Newton, MA, known for her significant contributions in the field of neuroscience and psychiatry. With a total of 18 patents to her name, her work has considerably advanced our understanding of attention deficit-hyperactivity disorder (ADHD) and the mechanisms underlying this condition.
Latest Patents
One of her latest patents presents methods for diagnosing and monitoring treatment for ADHD by assessing the dopamine transporter level. This groundbreaking method diagnoses attention deficit-hyperactivity disorder in a human patient by evaluating the dopamine transporter levels in specific regions of the central nervous system. An elevated level of dopamine transporter in a patient is indicative of ADHD. Moreover, this invention encompasses assessing dopamine transporter levels through the binding of a dopamine transporter ligand using PET or SPECT imaging techniques. Additionally, Bertha has developed novel tropane compounds along with methods for their use, further contributing to the pharmacological landscape.
Career Highlights
Throughout her career, Bertha K. Madras has been associated with esteemed institutions, including Harvard College and Organix, Inc. Her research at these organizations has laid a foundation for advancements in the diagnosis and treatment of neurological disorders.
Collaborations
Collaborative efforts have been pivotal in Bertha's innovative journey. She has worked alongside notable colleagues such as Peter C. Meltzer and Paul Blundell, combining their expertise to enhance their research outcomes and foster inventive solutions in psychiatry.
Conclusion
In conclusion, Bertha K. Madras stands as a beacon of innovation in her field, with her patents reflecting a profound impact on diagnostics and treatment methodologies for ADHD and beyond. Her dedication to research and development continues to inspire future advancements in neuroscience and beyond.